Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 2, 1996, Pages 455-461

  Baker, L E ^a   Makhay, M M ^a  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

(+) amphetamine; (+) fenfluramine; do pamine; drug discrimination; MDMA; rats; serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; FENFLURAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPLETION; DISCRIMINATIVE STIMULUS; DOPAMINERGIC SYSTEM; DRUG DISCRIMINATION; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ANIMALIA;

EID: 0030029003     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02017-9     Document Type: Article

References (41)

1. Baker, L. E.; Broadbent, J.; Michael, E. K.; Matthews, C. A.; Metosh, R. B.; West, W. B.; Appel, J. B. Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA). Behav Pharmacol. 6:263-275; 1995.
2. Balster, R. L.; Schuster, C. R. A comparison of (+)-amphetamine, 1-amphetamine and methamphetamine self-administration in rhesus monkeys. Pharmacol Biochem. Behav. 1:67-71; 1973.
3. Barnes, D. M. Neurotoxicity creates regulatory dilemma. Science 243:29-30; 1989.
4. Chait, L. D.; Uhlenhuth, E. H.; Johanson, C. E. The discriminative stimulus and subjective effects of (+)-amphetamine, phenmetrazine and fenfluramine in humans. Psychopharmacology (Berlin) 89:301-306; 1986.
5. Climko, R. P.; Roehrich, H.; Sweeney, D. R.; Al-Razi, J. Ecstasy: A review of MDMA and MDA. Int. J. Psychiatr. Med. 16: 359-372; 1987.
6. Cox, R. H.; Maickel, R. P. Comparison of anorexigenic and behavioral potency of phenylethylamines. J. Pharmacol. Exp. Ther. 181:1-9; 1972.
7. Evans, S. M.; Johanson, C. E. Discriminative stimulus properties of (±)-3,4-methylenedioxymethamphetamine and (±)-3,4-methylenedioxyamphetamine in pigeons. Drug Alcohol Depend. 18: 159-164; 1986.
8. Evans, S. M.; Johanson, C. E. Amphetamine-like effects of anorectics and related compounds in pigeons. J. Pharmacol. Exp. Ther. 241:817-825; 1987.
9. Evans, S. M.; Zancy, J. P.; Johanson, C. E. Three-choice discrimination among (+)-amphetamine, fenfluramine and saline in pigeons. Pharmacol. Biochem. Behav. 35:971-980; 1990.
10. Extance, K.; Goudie, A. J. Inter-animal olfactory cues in operant drug discrimination procedures in rat. Psychopharmacology (Berlin) 91:67-73; 1981.
11. Glennon, R. A.; Higgs, R. Investigation of MDMA-related agents in rats trained to discriminate MDMA from saline. Pharmacol. Biochem. Behav. 43:759-763; 1992.
12. Glennon, R. A.; Misenheimer, B. R. Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH-MDA) in rats trained to discriminate MDMA from saline. Pharmacol. Biochem. Behav. 33:909-912; 1989.
13. Glennon, R. A.; Young, R. Further investigation of the discriminative stimulus properties of MDA. Pharmacol. Biochem. Behav. 20:501-505; 1984.
14. Glennon, R. A.; Yousif, M.; Patrick, G. Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs. Pharmacol. Biochem. Behav. 29:443-449; 1988.
15. 3 antagonists. Pharmacol. Biochem. Behav. 43:1099-1106; 1992.
16. Glowinski, L. Effects of amphetamine on various aspects of catecholamine metabolism in the central nervous system of the rat. In: Costa, E.; Garattini, S., eds. Amphetamines and related compounds. New York: Raven Press; 1970:301-316.
17. Gotestam, K. G.; Gunne, L.-M. Subjective effects of two anorexigenic agents fenfluramine and AN 448 in amphetamine-dependent subjects. Br. J. Addict. 67:39-44; 1972.
18. Goudie, A. J. Discriminative stimulus properties of fenfluramine in an operant task: An analysis of its cue function. Psychopharmacology (Berlin) 53:97-102; 1977.
19. Griffith, J. D.; Nutt, J. G.; Jasinski, D. R. A comparison of fenfluramine and amphetamine in man. Clin. Pharmacol. Ther. 18:563-570; 1975.
20. Harvey, J. A.; McMaster, S. E. Fenfluramine: Evidence for a neurotoxic action on a long-term depletion of serotonin. Psychopharmacol. Commun. 1:217-228; 1975.
21. Jespersen, S.; Scheel-Kruger, J. Evidence for a difference in mechanism of action between fenfluramine and amphetamine induced anorexia. J. Pharm. Pharmacol. 25:49-54; 1973.
22. Johanson, C. E.; Uhlenhuth, E. H. Drug preferences in humans. Fed. Proc. 41:228-233; 1982.
23. 3H]dopamine release from superfused rat brain slices. Eur. J Pharmacol. 132:269-276; 1986.
24. Johnson, M. P.; Nichols, D. E. Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine. Pharmacol. Biochem. Behav. 36:105-109; 1990.
25. Kamien, J. B.; Johanson, C. E.; Schuster, C. R.; Woolverton, W. L. The effects of (±)-methylenedioxymethamphetamine and (±)-methytenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline. Drug Alcohol Depend. 18: 139-147; 1986.
26. Kleven, M. S.; Schuster, C. R.; Seiden, L. S. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. J. Pharmacol. Exp. Ther. 246:822-828; 1988.
27. Li, A. A.; Marek, G. J.; Vosmer, G.; Seiden, L. S. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Pharmacol. Biochem. Behav. 33:641-648; 1989.
28. Nichols, D. E. Differences between the mechanism of action of MDMA, MBDB and the classic hallucinogens. Identification of a new therapeutic class: Entactogens. J. Psychoactive Drugs 18: 305-313; 1986.
29. Nichols, D. E.; Hoffman, A. J.; Oberlender, R. A.; Jacob, P., III; Shulgin, A. T. Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: Representatives of a novel therapeutic class. J. Med. Chem. 29:2009-2015; 1986.
30. Oberlender, R.; Nichols, D. E. Drug discrimination studies with MDMA and amphetamine. Psychopharmacology (Berlin) 95:71-76; 1988.
31. Peroutka, S. J.; Newman, H.; Harris, H. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1:273-277; 1988.
32. Schechter, M. D. Discriminative profile of MDMA. Pharmacol. Biochem. Behav. 24:1533-1537; 1986.
33. Schechter, M. D. Serotonergic-dopaminergic mediation of 3,4-methytenedioxymethamphetamine (MDMA, "Ecstasy"). Pharmacol. Biochem. Behav. 31:817-824; 1989.
34. Schechter, M. D. Functional consequences of fenfluramine neurotoxicity. Pharmacol. Biochem. Behav. 37:623-626; 1990.
35. Schechter, M. D. Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination. Pharmacol. Biochem. Behav. 38:539-544; 1991.
36. Schechter, M. D. Effect of serotonin depletion by p-chlorophenylalanine upon discriminative behaviours. Gen. Pharmacol. 22:889-893; 1991.
37. Schmidt, C. J. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 240:1-7; 1987.
38. Schmidt, C. J.; Levin, J. A.; Lovenberg, W. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem. Pharmacol. 36:747-755; 1987.
39. Stone, D. M.; Johnson, M.; Hanson, G. R.; Gibb, J. W. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 249:79-87; 1988.
40. Woods, J. H.; Tessel, R. E. Fenfluramine: Amphetamine congener that fails to maintain drug-taking behavior in the rhesus monkey. Science 185:1067-1069; 1974.
41. Ziance, R. L.; Sipes, I. G.; Kinnard, W. J.; Buckley, J. P. Central nervous system effects of fenfluramine hydrochloride. J. Pharmacol. Exp. Ther. 180:110-117; 1972.